sarcosine has been researched along with Neoplasms in 10 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "GSK923295 is an inhibitor of CENP-E, a key cellular protein important in the alignment of chromosomes during mitosis." | 2.77 | First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. ( Botbyl, JD; Chung, V; Heath, EI; Holen, KD; Johnson, BM; Kirby, LC; Lampkin, TA; Lynch, KM; Schelman, WR, 2012) |
| "We used datasets from the Cancer Cell Line Encyclopedia (CCLE) phase II project and treated metabolomic data as tensor predictors and data on gene expression of metabolic enzymes as confounding covariates." | 1.91 | Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers. ( Huang, TH; Li, CI; Lin, PC; Shen, MR; Tsai, YS; Yeh, YM, 2023) |
| "Sarcosine-treated DC vaccines resulted in significantly improved tumor control in a B16F10-OVA tumor flank model and improved survival in an intracranial GL261-gp100 glioma model." | 1.51 | Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. ( Azari, H; Dastmalchi, F; Dechkovskaia, A; Karachi, A; Lovaton, RE; Mitchell, DA; Rahman, M; Saia, ME; Sayour, EJ; Vlasak, AL; Yang, C, 2019) |
| "NIRF imaging of a small cancer on mouse by using the peptosome as a nanocarrier was successful due to the EPR effect of the peptosome." | 1.35 | Near-infrared fluorescent labeled peptosome for application to cancer imaging. ( Hiraoka, M; Kimura, S; Kizaka-Kondoh, S; Makino, A; Tanaka, S; Tanisaka, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, CI | 1 |
| Yeh, YM | 1 |
| Tsai, YS | 1 |
| Huang, TH | 1 |
| Shen, MR | 1 |
| Lin, PC | 1 |
| Dastmalchi, F | 1 |
| Karachi, A | 1 |
| Yang, C | 1 |
| Azari, H | 1 |
| Sayour, EJ | 1 |
| Dechkovskaia, A | 1 |
| Vlasak, AL | 1 |
| Saia, ME | 1 |
| Lovaton, RE | 1 |
| Mitchell, DA | 1 |
| Rahman, M | 1 |
| Hu, Y | 1 |
| Hou, Y | 1 |
| Wang, H | 1 |
| Lu, H | 1 |
| Lee, WH | 1 |
| Liu, HE | 1 |
| Chang, JY | 1 |
| Liou, JP | 1 |
| Huang, HM | 1 |
| Zhu, H | 1 |
| Chen, Y | 1 |
| Yan, FJ | 1 |
| Chen, J | 1 |
| Tao, XF | 1 |
| Ling, J | 1 |
| Yang, B | 1 |
| He, QJ | 1 |
| Mao, ZW | 1 |
| Sano, K | 1 |
| Ohashi, M | 1 |
| Kanazaki, K | 1 |
| Makino, A | 4 |
| Ding, N | 1 |
| Deguchi, J | 1 |
| Kanada, Y | 1 |
| Ono, M | 1 |
| Saji, H | 1 |
| Kizaka-Kondoh, S | 2 |
| Yamahara, R | 2 |
| Hara, I | 2 |
| Kanzaki, T | 1 |
| Ozeki, E | 2 |
| Hiraoka, M | 2 |
| Kimura, S | 3 |
| Chung, V | 1 |
| Heath, EI | 1 |
| Schelman, WR | 1 |
| Johnson, BM | 1 |
| Kirby, LC | 1 |
| Lynch, KM | 1 |
| Botbyl, JD | 1 |
| Lampkin, TA | 1 |
| Holen, KD | 1 |
| Hara, E | 1 |
| Kurihara, K | 1 |
| Yamamoto, F | 1 |
| Tanisaka, H | 1 |
| Tanaka, S | 1 |
1 trial available for sarcosine and Neoplasms
| Article | Year |
|---|---|
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer.
Topics: Adult; Aged; Antimitotic Agents; Bridged Bicyclo Compounds, Heterocyclic; Chromosomal Proteins, Non- | 2012 |
9 other studies available for sarcosine and Neoplasms
| Article | Year |
|---|---|
Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers.
Topics: Biomarkers, Tumor; Gene Expression; Glyceric Acids; Humans; Microsatellite Instability; Neoplasms; S | 2023 |
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
Topics: Adoptive Transfer; Animals; Biomarkers; Cancer Vaccines; Cell Movement; Dendritic Cells; Disease Mod | 2019 |
Polysarcosine as an Alternative to PEG for Therapeutic Protein Conjugation.
Topics: Animals; Antibody Formation; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Interferon | 2018 |
MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M arrest in nonresistant and paclitaxel-resistant cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; | 2013 |
Polysarcosine brush stabilized gold nanorods for in vivo near-infrared photothermal tumor therapy.
Topics: A549 Cells; Animals; Biocompatible Materials; Blood Circulation; Cell Survival; Colloids; Gold; Hype | 2017 |
Indocyanine Green-Labeled Polysarcosine for in Vivo Photoacoustic Tumor Imaging.
Topics: Animals; Cell Line, Tumor; Endocytosis; Humans; Indocyanine Green; Mice; Neoplasms; Peptides; Photoa | 2017 |
Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide.
Topics: Animals; Cell Line, Tumor; Diagnostic Imaging; Fluorescence; Humans; Lactic Acid; Male; Mice; Mice, | 2009 |
Control of in vivo blood clearance time of polymeric micelle by stereochemistry of amphiphilic polydepsipeptides.
Topics: Animals; Cell Line; Depsipeptides; Fluorescent Dyes; Humans; Indocyanine Green; Lactic Acid; Mice; M | 2012 |
Near-infrared fluorescent labeled peptosome for application to cancer imaging.
Topics: Animals; Circular Dichroism; Drug Carriers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Infrared | 2008 |